Alimera Sciences, Inc. - Common Stock (ALIM)

ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

MicroAlgo stock is up on Monday after the company revealed in an SEC filing that an investor now holds an almost 14% stake in MLGO.

Alimera Sciences stock is up on Monday as investors react to a $5.50 per share acquisition offer for ALIM from ANI Pharmaceuticals.

ANI Pharmaceuticals to acquire Alimera Sciences for $5.50 per share in cash, plus a contingent value right of up to $0.50 per share. The transaction is valued at $381 million and is expected to close in Q3 2024.

ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

ALIM stock results show that Alimera Sciences beat on revenue for the fourth quarter of 2023.

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares climbed 148.3% to $29.18 after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of 2,374,641 shares of its Class A Common Stock priced at $7.25 per share.

Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of 2,374,641 shares of its Class A

It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday!

Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.